Clock Model Blood Test Predicts Alzheimer’s Onset
New FNIH study in Nature Medicine shows a single blood test can predict Alzheimer’s risk and estimate symptom onset within 3 to 4 years, aiding trials.
New FNIH study in Nature Medicine shows a single blood test can predict Alzheimer’s risk and estimate symptom onset within 3 to 4 years, aiding trials.
Dr Natàlia Vilor Tejedor explores genetics, risk factors and neuroinflammation in Alzheimer disease in this DEMON Biomarkers Group talk recorded 11 Feb 2026.
New research uses network analysis to show how Lewy body dementia symptoms connect, highlighting visual hallucinations and bladder symptoms as central features.
A new Alzheimer Europe report estimates dementia across Europe could rise by almost two thirds by 2050, increasing pressure on health, care, and research.
New research uses brain scans to spot Lewy body dementia earlier. John O’Brien and Elena Herrero explain how imaging could improve diagnosis and care.
A Danish study of 17,711 people found late life depression was more common before Parkinson’s and Lewy body dementia, suggesting early neurodegenerative change.
Lewy Body Dementia Association webinar reviewing 2025 advances in Lewy body dementia research including diagnostics biomarkers and clinical trials
The University of Bradford has £2.4m from NIHR to lead a clinical trial to improve care for swallowing difficulties, including dementia.
Round two of SPIN D Flexible Funding is open. This session explains the schemes, eligibility, PPI expectations and tips to shape a strong application.
SmartSocks®DISCOVERY Pioneers winners announced, backing new research in dementia, stress and sleep with wearable sensing kits from Milbotix.
Ten Salon Debates now free to watch. Peer review, funding, AI, care, genetics, burnout and leadership, debated by researchers across dementia research.
New MRC NIHR Centre of Research Excellence backed by £50m will transform clinical trial design, speed delivery, and improve access to effective treatments.